期刊
ANTICANCER RESEARCH
卷 40, 期 10, 页码 5329-5341出版社
INT INST ANTICANCER RESEARCH
DOI: 10.21873/anticanres.14540
关键词
PBMCs; humanized mice; immunotherapy; cancer; immuno-oncology; review
类别
资金
- Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health
Investigation of the efficacy and mechanisms of human immuno-oncology agents has been hampered due to species-specific differences when utilizing preclinical mouse models. Peripheral blood mononuclear cell (PBMC) humanized mice provide a platform for investigating the modulation of the human immune-mediated antitumor response while circumventing the limitations of syngeneic model systems. Use of humanized mice has been stymied by model-specific limitations, some of which include the development of graft versus host disease, technical difficulty and cost associated with each humanized animal, and insufficient engraftment of some human immune subsets. Recent advances have addressed many of these limitations from which have emerged humanized models that are more clinically relevant. This review characterizes the expanded usage, advantages and limitations of humanized mice and provides insights into the development of the next generation of murine humanized models to further inform clinical applications of cancer immunotherapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据